GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Acquired by Dodge & Cox

Dodge & Cox raised its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 16,675,508 shares of the company’s stock after buying an additional 11,867 shares during the quarter. Dodge & Cox owned 3.65% of GE HealthCare Technologies worth $1,303,691,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. CoreFirst Bank & Trust purchased a new position in GE HealthCare Technologies in the fourth quarter valued at about $25,000. Runnymede Capital Advisors Inc. bought a new stake in GE HealthCare Technologies during the 4th quarter valued at approximately $28,000. Bank of Jackson Hole Trust acquired a new stake in shares of GE HealthCare Technologies in the fourth quarter worth $32,000. OFI Invest Asset Management bought a new position in shares of GE HealthCare Technologies during the 4th quarter worth about $34,000. Finally, Flagship Wealth Advisors LLC acquired a new stake in shares of GE HealthCare Technologies during the 4th quarter worth approximately $34,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $64.39 on Tuesday. The stock has a market capitalization of $29.45 billion, a P/E ratio of 14.87, a P/E/G ratio of 3.19 and a beta of 1.14. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $94.80. The company’s 50-day moving average is $81.29 and its 200 day moving average is $83.80.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. The firm had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. On average, sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Friday, April 25th will be given a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.22%. The ex-dividend date of this dividend is Friday, April 25th. GE HealthCare Technologies’s dividend payout ratio is currently 3.23%.

Analysts Set New Price Targets

A number of research firms have commented on GEHC. The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $85.00 to $100.00 in a research note on Tuesday, March 11th. Citigroup lifted their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday, February 13th. Wells Fargo & Company increased their price target on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, February 14th. Finally, Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, eight have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $97.73.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.